Harnessing frontier cancer targets through exceptional drug discovery that is inspired by nature’s lessons

REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. The company’s innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches.

Year Invested: 2015
Location: Redwood City, Calif.
Visit: www.revolutionmedicines.com

Recent News

October 5, 2017
REVOLUTION Medicines Appoints Vincent Miller, M.D. to Board of Directors

September 14, 2017
REVOLUTION Medicines Reports Discovery that May Expand Range of Clinically Actionable Cancer Mutations

March 20, 2017
REVOLUTION Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development

Read More News

Associated Team Members

Mark A. Goldsmith, M.D., Ph.D.
Venture Partner

Alexis Borisy

Neil Exter